Progressive 3-Month Increase in LV Myocardial ECV After Anthracycline-Based Chemotherapy

JACC Cardiovasc Imaging. 2017 Jun;10(6):708-709. doi: 10.1016/j.jcmg.2016.06.006. Epub 2016 Aug 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Anthracyclines / adverse effects*
  • Antibiotics, Antineoplastic / adverse effects*
  • Cardiotoxicity
  • Disease Progression
  • Extracellular Matrix / pathology
  • Female
  • Fibrosis
  • Humans
  • Hypertrophy, Left Ventricular / chemically induced*
  • Hypertrophy, Left Ventricular / diagnostic imaging
  • Hypertrophy, Left Ventricular / physiopathology
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Myocardium / pathology
  • Time Factors
  • Ventricular Dysfunction, Left / chemically induced*
  • Ventricular Dysfunction, Left / diagnostic imaging
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Function, Left / drug effects*
  • Ventricular Remodeling / drug effects*

Substances

  • Anthracyclines
  • Antibiotics, Antineoplastic